Search
01/02/2025
Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery)
Abril-Pérez, C, Mansilla-Polo, M, Escutia-Muñoz, B, Sanmartín, O, Garcés, JR, Rodríguez-Prieto, MA, Ruiz-Salas, V, de Eusebio-Murillo, E, Miñano-Medrano, R, González-Sixto, B, Artola-Igarza, JL, Alfaro-Rubio, A, Redondo, P, Delgado-Jiménez, Y, Sánchez-Schmidt, JM, Allende-Markixana, I, Alonso-Pacheco, ML, García-Bracamonte, B, de la Cueva-dobao, P, Navarro-Tejedor, R, Ciudad-Blanco, C, Carnero-González, L, Vázquez-Veiga, H, Cano-Martínez, N, Serra-Guillén, C, Vilarrasa, E, Sánchez-Sambucety, P, López-Estebaranz, JL, Flórez-Menéndez, A, Martorell-Calatayud, A, Gil, P, Morales-Gordillo, V, Toll, A, Ocerin-Guerra, I, Mayor-Arenal, M, Suárez-Fernández, R, Sainz-Gaspar, L, Descalzo, MA, Garcia-Doval, I, Botella-Estrada, R. Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery). JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39(2)DOI:10.1111/jdv.20103. PMID:38733285. IF:8.000(Q1/1D).
01/02/2025
Clinical impact of complex percutaneous coronary intervention in the pre-TAVR workup
Avvedimento, M, Campelo-Parada, F, Nombela-Franco, L, Fischer, Q, Donaint, P, Serra, V, Veiga, G, Gutierrez, E, Franzone, A, Vilalta, V, Alperi, A, Regueiro, A, Asmarats, L, Ribeiro, HB, Matta, A, Muñoz-García, A, Tirado, G, Urena, M, Metz, D, Rodenas-Alesina, E, Hernández, JMD, Angellotti, D, Fernández-Nofrerías, E, Pascual, I, Vidal-Calés, P, Arzamendi, D, Campanha-Borges, DC, Trinh, KH, Nuche, J, Côté, M, Faroux, L, Rodés-Cabaua, J. Clinical impact of complex percutaneous coronary intervention in the pre-TAVR workup. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(2)DOI:10.1016/j.rec.2024.05.002. PMID:38763211. IF:4.900(Q1/2D).
01/02/2025
Centenarians-the way to healthy vascular ageing and longevity: a review from VascAgeNet
Summer, S, Borrell-Pages, M, Bruno, RM, Climie, RE, Dipla, K, Dogan, A, Eruslanova, K, Fraenkel, E, Mattace-Raso, F, Pugh, CJA, Rochfort, KD, Ross, M, Roth, L, Schmidt-Trucksaess, A, Schwarz, D, Shadiow, J, Sohrabi, Y, Sonnenberg, J, Tura-Ceide, O, Tuna, BG, Julve, J, Dogan, S. Centenarians-the way to healthy vascular ageing and longevity: a review from VascAgeNet. GeroScience. 2025; 47(1)DOI:10.1007/s11357-024-01467-8. PMID:39725804. IF:5.400(Q1/1D).
01/02/2025
Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society
Pedro-Botet, J, Arrieta, F, Botana, M, Gimeno-Orna, JA, Martinez-Montoro, JI, de Victoria, EOM, Ribalta, J, Sánchez-Margalet, V, Pérez-Pérez, A. Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society. Endocrinologia Diabetes y Nutricion. 2025; 72(2)DOI:10.1016/j.endien.2025.101523. PMID:39924389. IF:1.800(Q3/8D).
01/02/2025
Increased copeptin may reflect vasopressin-related metabolic changes after bariatric surgery
Galbiati, F, Becetti, I, Lauze, M, Aulinas, A, Singhal, V, Bredella, MA, Lawson, EA, Misra, M. Increased copeptin may reflect vasopressin-related metabolic changes after bariatric surgery. Obesity. 2025; 33(2)DOI:10.1002/oby.24200. PMID:39725569. IF:4.700(Q1/2D).
01/02/2025
Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study
Guerrero-Pérez, F, Biagetti, B, Paja-Fano, M, Menéndez-Torre, EL, Rivero, G, Dios, E, Hanzu, FA, Rojas-Marcos, PM, Irigaray, A, Rodríguez, MDM, García-Centeno, R, Fernández, LG, Enseñat, J, Mora, M, Villar-Taibo, R, García, IMO, Araujo-Castro, M, Gándara, C, García, MDO, Tenorio-Jiménez, C, Novo-Rodriguez, C, Civantos, S, Simó-Servat, A, Aulinas, A, Asla, Q, Cordido, F, Novoa-Testa, I, Xifra, G, Ayala-Conte, M, Zamarron, A, Berrocal, MIG, Iglesias, P. Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study. Pituitary. 2025; 28(1)DOI:10.1007/s11102-024-01484-y. PMID:39733084. IF:3.400(Q2/4D).
01/02/2025
Progressive systemic inflammation precedes decompensation in compensated cirrhosis
Sánchez-Aldehuelo, R, Villanueva, C, Genescà, J, García-Pagán, JC, Castillo, E, Calleja, JL, Aracil, C, Bañares, R, Téllez, L, Paule, L, Morillas, RM, Poca, M, Peñas, B, Augustin, S, Abraldes, JG, Alvarado-Tapias, E, Bosch, J, Albillos, A. Progressive systemic inflammation precedes decompensation in compensated cirrhosis. Jhep Reports. 2025; 7(2)DOI:10.1016/j.jhepr.2024.101231. PMID:39850960. IF:7.500(Q1/2D).
01/02/2025
Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU
Mesonero, F, Zabana, Y, Fernández-Clotet, A, Solá, A, Caballol, B, Leo-Carnerero, E, García, MJ, Bertoletti, F, Bastida, G, Suris, G, Casis, B, Ferreiro-Iglesias, R, Calafat, M, Jiménez, I, Miranda-Bautista, J, Lamuela, LJ, Fajardo, I, Torrealba, L, Nájera, R, Sáiz-Chumillas, RM, González-Partida, I, Vicuña, M, García-Morales, N, Gutiérrez, A, López-García, A, Benitez, JM, de Célix, CR, Tejido, C, Brunet, E, Hernandez-Camba, A, Suárez, C, Rodríguez-Lago, I, Piqueras, M, Castaño, A, Ramos, L, Sobrino, A, Rodríguez-Grau, MC, Elosua, A, Montoro, M, Baltar, R, Huguet, JM, Hermida, B, Caballero-Mateos, A, Sánchez-Guillén, L, Bouhmidi, A, Pajares, R, Baston-Rey, I, López-Sanromán, A, Albillos, A, Barreiro-de Acosta, M. Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU. DIGESTIVE AND LIVER DISEASE. 2025; 57(2)DOI:10.1016/j.dld.2024.09.023. PMID:39455313. IF:3.800(Q2/3D).
01/02/2025
Alcohol-associated liver disease: Natural history, management and novel targeted therapies
Alvarado-Tapias, E, Pose, E, Gratacós-Ginès, J, Clemente-Sánchez, A, López-Pelayo, H, Bataller, R. Alcohol-associated liver disease: Natural history, management and novel targeted therapies. Clinical and Molecular Hepatology. 2025; 31DOI:10.3350/cmh.2024.0709. PMID:39481875. IF:16.900(Q1/1D).
01/02/2025
Asymptomatic Inflammatory Bowel Disease Diagnosed During Colorectal Cancer Population Screening in Catalonia: Characteristics and Natural History
Brunet-Mas, E, Selva, A, Bas-Cutrina, F, Brujats, A, Caballol, B, Font, R, Gómez, B, Gonzalez-Muñosa, C, Busquets, D, Monfort, D, Vera, DP, Maristany, E, Cirera, G, Torres, G, Castro-Poceiro, J, Lopez, J, Gonzalez-Gonzalez, L, Márquez-Mosquera, L, Gallach, M, Esteve, M, Tremosa, G, Torra, S, Robles-Alonso, V, Garcia-Iglesias, P, Rodríguez-Lago, I, Calvet, X. Asymptomatic Inflammatory Bowel Disease Diagnosed During Colorectal Cancer Population Screening in Catalonia: Characteristics and Natural History. Clinical and Translational Gastroenterology. 2025; 16(2)DOI:10.14309/ctg.0000000000000740. PMID:39729123. IF:3.000(Q2/4D).
01/02/2025
Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: a prospective multicenter study
Mancheño-Losa, M, Murillo, O, Benavent, E, Sorlí, L, Riera, M, Cobo, J, Benito, N, Morata, L, Ribera, A, Sobrino, B, Fernández-Sampedro, M, Múñez, E, Bahamonde, A, Barbero, JM, del Toro, MD, Villa, J, Rigo-Bonnin, R, Luque, S, García-Luque, I, Oliver, A, Esteban, J, Lora-Tamayo, J. Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: a prospective multicenter study. INFECTION. 2025; 53(1)DOI:10.1007/s15010-024-02379-7. PMID:39249177. IF:3.600(Q2/3D).
01/02/2025
Blood CD45+/CD3+ lymphocyte-released extracellular vesicles and mortality in hospitalized patients with coronavirus disease 2019
Suades, R, Greco, MF, Padró, T, de Santisteban, V, Domingo, P, Benincasa, G, Napoli, C, Greco, S, Madè, A, Ranucci, M, Devaux, Y, Martelli, F, Badimon, L. Blood CD45+/CD3+ lymphocyte-released extracellular vesicles and mortality in hospitalized patients with coronavirus disease 2019. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55(2)DOI:10.1111/eci.14354. PMID:39548690. IF:3.600(Q1/2D).
01/02/2025
Prognostic significance of mutation type and chromosome fragility in Fanconi anemia
Ramírez, MJ, Pujol, R, Minguillón, J, Bogliolo, M, Persico, I, Cavero, D, de la Cal, A, Río, P, Navarro, S, Casado, JA, Bailador, A, de la Fuente, AS, de Heredia, ML, Almazán, F, Antelo, ML, Argilés, B, Badell, I, Baragaño, M, Beléndez, C, Bermúdez, M, Bernués, M, Buedo, MI, Carrasco, E, Català, A, Costa, D, Cuesta, I, Fernández-Delgado, R, Fernández-Teijeir, A, Figuera, A, García, M, Gondra, A, González, M, Muñiz, SG, Hernández-Rodríguez, I, Ibañez, F, Kelleher, NJ, Lendínez, F, López, M, López-Almaraz, R, Marchante, I, Mendoza, C, Nieto, J, Ojeda, E, Payán-Pernía, S, Peláez, I, de Soto, IP, Portugal, R, Ramos-Arroyo, MA, Regueiro, A, Rodríguez, A, Rosell, J, Saez, R, Sánchez, J, Sánchez, M, Senent, ML, Tapia, M, Trujillo-Quintero, JP, Vagace, JM, Verdú-Amorós, J, Verdugo, V, Vidales, I, Villarreal, J, Díaz-de-Heredia, C, Sevilla, J, Bueren, J, Surralles, J. Prognostic significance of mutation type and chromosome fragility in Fanconi anemia. AMERICAN JOURNAL OF HEMATOLOGY. 2025; 100(2)DOI:10.1002/ajh.27520. PMID:39562502. IF:9.900(Q1/1D).
01/02/2025
A cross-sectional analysis from a real-world cohort of patients with microsatellite instability colorectal cancer (MSI-CRC) with metastatic disease from the Spanish RETUD registry.
Castro, CG, López, S, Garcia-Alfonso, P, Martinez, CF, González, BD, Ortiz, MJ, Paez, D, Lopez, CM, La Casta, A, Sosa, MM, Valera, JS, Ghanem, I, Vidal-Tocino, R, Santos, C, Garcia-Benito, C, Jimenez, E, Guillot, M, Verdaguer, H, Montes, AFF. A cross-sectional analysis from a real-world cohort of patients with microsatellite instability colorectal cancer (MSI-CRC) with metastatic disease from the Spanish RETUD registry.. JOURNAL OF CLINICAL ONCOLOGY. 2025; 43(4_SUPPL)DOI:10.1200/JCO.2025.43.4_suppl.178. PMID:. IF:41.900(Q1/1D).
01/02/2025
Plasma shallow whole-genome sequencing profiling in patients with RASWT metastatic colorectal cancer (mCRC) undergoing first-line anti-EGFR therapy.
Martelli, V, Barrull, JV, Fernandez-Rodríguez, C, Gibert, J, Moreno, A, Louhamane, A, Linares-Aceituno, J, Garcia-Alfonso, P, Paez, D, Alonso, V, Espana, MAG, Santos, C, Duran, G, Elez, E, Paricio, BB, Tabernero, J, Salazar, R, Aranda, E, Toledo, RA, Montagut, CO. Plasma shallow whole-genome sequencing profiling in patients with RASWT metastatic colorectal cancer (mCRC) undergoing first-line anti-EGFR therapy.. JOURNAL OF CLINICAL ONCOLOGY. 2025; 43(4_SUPPL)DOI:10.1200/JCO.2025.43.4_suppl.214. PMID:. IF:41.900(Q1/1D).
01/02/2025
A cross-sectional analysis from a real-world cohort of patients with microsatellite instability colorectal cancer (MSI-CRC) with localized disease from the Spanish RETUD registry.
Montes, AFF, Lopez, CM, Lopez, S, Martinez, CF, Paez, D, Gonzalez, BD, Espana, MAG, Garcia-Benito, C, Vidal-Tocino, R, Sosa, MM, Valera, JS, Garcia-Alfonso, P, Ghanem, I, La Casta, A, Gallego, J, Verdaguer, H, Santos, C, Jimenez, E, Gravalos, C. A cross-sectional analysis from a real-world cohort of patients with microsatellite instability colorectal cancer (MSI-CRC) with localized disease from the Spanish RETUD registry.. JOURNAL OF CLINICAL ONCOLOGY. 2025; 43(4_SUPPL)DOI:10.1200/JCO.2025.43.4_suppl.173. PMID:. IF:41.900(Q1/1D).
01/02/2025
Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research Recommendations in Women with Breast Cancer
Olmos, VP, Pollán, M, de Larrea-Baz, NF, Fernández-Morata, J, Ruiz-Moreno, E, García-Pérez, J, Castelló, A, Sierra, MA, Lucas, P, Alonso-Ledesma, I, Stradella, A, Cantos, B, Cajal, TRY, Santisteban, M, Seguí, MA, Bertrán, AS, Granja, M, Camps-Herrero, J, Recalde, S, Mendez, M, Verges, NC, Pérez-Gómez, B, Pastor-Barriuso, R, Lope, V. Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research Recommendations in Women with Breast Cancer. Cancers. 2025; 17(4)DOI:10.3390/cancers17040708. PMID:40002301. IF:4.400(Q2/3D).
01/02/2025
PATH classification: a proposal for patients with HNSCC treated with salvage surgery
Llansana, A, Porcuna, DV, Vasquez, R, Parellada, A, Valero, C, Holgado, A, León, X. PATH classification: a proposal for patients with HNSCC treated with salvage surgery. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2025; 282(2)DOI:10.1007/s00405-024-08961-x. PMID:39312000. IF:2.200(Q1/3D).
01/02/2025
Next-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell features
Sierro-Martinez, B, Escamilla-Gomez, V, Perez-Ortega, L, Guijarro-Albaladejo, B, Hernandez-Diaz, P, de la Rosa-garrido, M, Lara-Chica, M, Rodriguez-Gil, A, Reguera-Ortega, JL, Sanoja-Flores, L, Arribas-Arribas, B, Montiel-Aguilera, MA, Carmona, G, Robles, MJ, Caballero-Velazquez, T, Briones, J, Einsele, H, Hudecek, M, Perez-Simon, JA, Garcia-Guerrero, E. Next-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell features. CELLULAR ONCOLOGY. 2025; 48(1)DOI:10.1007/s13402-024-00984-0. PMID:39192092. IF:4.800(Q1/1D).
01/02/2025
Role of Spatially Fractionated Radiotherapy (LATTICE) Treatment in Inoperable Bulky Soft-Tissue Sarcomas
Majercakova, K, Aguilar, NT, Verdum, JI, Bargallo, HV, Capel, AV, Soto, MM, Melcon, GGD, Cordero, JVR, Gonzalez-Lopez, JA, Rosell, SB, Jover, DH, Mitre, SR, Ibanez, AP, Sebio, A, Sancho-Pardo, G. Role of Spatially Fractionated Radiotherapy (LATTICE) Treatment in Inoperable Bulky Soft-Tissue Sarcomas. Cancers. 2025; 17(4)DOI:10.3390/cancers17040624. PMID:40002219. IF:4.400(Q2/3D).